Data / Drug companies / Holiday Labs Mexico, S.A. De C.V.
Holiday Labs Mexico, S.A. De C.V.: 25 products in the FDA NDC directory, labeler code 52286
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Holiday Labs Mexico, S.A. De C.V. (labeler code 52286) lists 25 products in the FDA National Drug Code Directory. By type: 25 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on October 10, 2017.
The request: Watch Holiday Labs Mexico, S.A. De C.V. (FDA labeler code 52286): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 52286
- Products in commercial distribution
- 25
- Packages
- 25
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 2, Schedule V 1
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- September 29, 2009
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 25 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 25 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 24 | 96% |
| Crystal | 1 | 4% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Rivaroxaban | 52286-0025 | Powder | Bulk ingredients | October 10, 2017 |
| Telmisartan | 52286-0024 | Powder | Bulk ingredients | March 21, 2017 |
| Cinacalcet hci | 52286-0023 | Powder | Bulk ingredients | November 25, 2014 |
| Pregabalin | 52286-0022 | Powder | Bulk ingredients | November 25, 2014 |
| Carisoprodol | 52286-0021 | Powder | Bulk ingredients | October 26, 2012 |
| Venlafaxine hydrochloride | 52286-0006 | Powder | Bulk ingredients | November 5, 2009 |
| Zolpidem tartrate | 52286-0004 | Powder | Bulk ingredients | November 5, 2009 |
| Pyrantel pamoate | 52286-0019 | Powder | Bulk ingredients | November 4, 2009 |
| Tolterodine tartrate | 52286-0018 | Powder | Bulk ingredients | November 4, 2009 |
| Rabeprazole sodium | 52286-0017 | Powder | Bulk ingredients | November 4, 2009 |
| Tropicamide | 52286-0010 | Powder | Bulk ingredients | November 4, 2009 |
| Metformin hydrochloride | 52286-0008 | Powder | Bulk ingredients | November 4, 2009 |
| Terbinafine hydrochloride | 52286-0007 | Powder | Bulk ingredients | November 4, 2009 |
| Oxibendazole | 52286-0002 | Powder | Bulk ingredients | November 4, 2009 |
| Halofantrine hydrochloride | 52286-4195 | Powder | Bulk ingredients | November 3, 2009 |
| Pyrantel tartrate zeolex | 52286-0020 | Powder | Bulk ingredients | November 3, 2009 |
| Levofloxacin hemihydrate | 52286-0016 | Powder | Bulk ingredients | November 3, 2009 |
| Ciprofloxacin hydrochloride | 52286-0015 | Crystal | Bulk ingredients | November 3, 2009 |
| Ciprofloxacin | 52286-0014 | Powder | Bulk ingredients | November 3, 2009 |
| Pantoprazole sodium sesquihydrate | 52286-0013 | Powder | Bulk ingredients | November 3, 2009 |
| Ketoconazole | 52286-0009 | Powder | Bulk ingredients | November 3, 2009 |
| Epsiprantel | 52286-0003 | Powder | Bulk ingredients | November 3, 2009 |
| Albendazole | 52286-0001 | Powder | Bulk ingredients | November 3, 2009 |
| Albendazole | 52286-5500 | Powder | Bulk ingredients | September 29, 2009 |
| Ciprofloxacin hydrochloride | 52286-0005 | Powder | Bulk ingredients | September 29, 2009 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.